(Tetrahydrofuran-2-yl)methyl butyrate, 95.0%, 500ml

N-(2,4-Dichlorobenzyl)hydroxylamine hydrochloride, 95.0%, 5g

(1S)-1-(4-BROMOPHENYL)PROPAN-1-AMINE, 95.0%, 100mg

GC capillary column ROTI®Cap-5 HT, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Benzyl 4-(2-oxoethyl)piperidine-1-carboxylate, 95.0%, 1g

5-(Trifluoromethyl)uracil>97.0%(HPLC)5g

Dimethyl(n-octyl)(3-sulfopropyl)ammonium Hydroxide Inner Salt [for Biochemical Research]>98.0%(HPLC)(N)5g

Chroman-8-carbaldehyde, 97.0%, 250mg

2,5-Bis(2-octyldodecyl)-3,6-bis[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl]pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione>98.0%(HPLC)200mg

GC capillary column ROTI®Cap-5 MS, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

ETHYL 6-(DIFLUOROMETHYL)NICOTINATE, 95.0%, 100mg

tert-Butyl 3-cyano-4-fluorobenzylcarbamate, 97%, 250mg

(2-Methylpyridin-3-yl)methanamine, 95.0%, 250mg